Resultados da busca - David Back

Refinar Resultados
  1. 1
    The challenge of HIV treatment in an era of polypharmacy

    The challenge of HIV treatment in an era of polypharmacy por David Back, Catia Marzolini

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Interaction Between Amiodarone and Sofosbuvir-based Treatment for Hepatitis C Virus Infection: Potential Mechanisms and Lessons to be Learned

    Interaction Between Amiodarone and Sofosbuvir-based Treatment for Hepatitis C Virus Infection: Potential Mechanisms and Lessons to be Learned por David Back, David M. Burger

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Carta
    Salvar na lista
    Na minha lista:
  3. 3
    New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals

    New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals por Kay Seden, David Back, Saye Khoo

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Maraviroc: Pharmacokinetics and drug Interactions

    Maraviroc: Pharmacokinetics and drug Interactions por Sylvie Abel, David Back, Manoli Vourvahis

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes

    Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes por Victoria A. Eagling, John Tjia, David Back

    Publicado em 1998
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors

    Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors por Louise Profit, Victoria A. Eagling, David Back

    Publicado em 1999
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir

    Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir por Victoria A. Eagling, David Back, Michael Barry

    Publicado em 1997
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Darunavir: Pharmacokinetics and Drug Interactions

    Darunavir: Pharmacokinetics and Drug Interactions por David Back, Vanitha Sekar, Richard M. W. Hoetelmans

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Fetal Compartment (Placenta and Amniotic Fluid)

    Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Fetal Compartment (Placenta and Amniotic Fluid) por Laura Else, Stephen Taylor, David Back, Saye Khoo

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  10. 10
    Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells

    Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells por Philip Martin, R Riley, David Back, Andrew Owen

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Cobicistat versus ritonavir boosting and differences in the drug–drug interaction profiles with co-medications

    Cobicistat versus ritonavir boosting and differences in the drug–drug interaction profiles with co-medications por Catia Marzolini, Sara Gibbons, Saye Khoo, David Back

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Differences in the cytochrome <i>P</i>-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 α-ethinyloestradiol. Relative activities of rat and human liver enzymes

    Differences in the cytochrome <i>P</i>-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 α-ethinyloestradiol. Relative activities of rat and human liver enzymes por S. Ball, Lesley M. Forrester, C. Roland Wolf, David Back

    Publicado em 1990
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Stopping antiretroviral therapy

    Stopping antiretroviral therapy por Stephen Taylor, Marta Boffito, Saye Khoo, Erasmus Smit, David Back

    Publicado em 2007
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  14. 14
    Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

    Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine por Daryl Hodge, David Back, Sara Gibbons, Saye Khoo, Catia Marzolini

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  15. 15
    Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro

    Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro por Patrick G. Hoggard, Stephen Kewn, Michael Barry, Saye Khoo, David Back

    Publicado em 1997
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patients

    Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patients por Concepta Merry, Michael Barry, Fiona Mulcahy, Kathryn L. Halifax, David Back

    Publicado em 1997
    Obter o texto integral
    Carta
    Salvar na lista
    Na minha lista:
  17. 17
    Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine

    Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine por Beth Williamson, Kelly E. Dooley, Yuan Zhang, David Back, Andrew Owen

    Publicado em 2013
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    The pharmacokinetics of methadone in HIV‐positive patients receiving the non‐nucleoside reverse transcriptase inhibitor efavirenz

    The pharmacokinetics of methadone in HIV‐positive patients receiving the non‐nucleoside reverse transcriptase inhibitor efavirenz por S Clarke, Fiona Mulcahy, John Tjia, Helen Reynolds, Sara E. Gibbons, Michael Barry, David Back

    Publicado em 2001
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    Pharmacokinetic Interactions of Nevirapine and Methadone and Guidelines for Use of Nevirapine to Treat Injection Drug Users

    Pharmacokinetic Interactions of Nevirapine and Methadone and Guidelines for Use of Nevirapine to Treat Injection Drug Users por S Clarke, Fiona Mulcahy, John Tjia, Helen Reynolds, Sara E. Gibbons, Michael Barry, David Back

    Publicado em 2001
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect

    Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect por Felix Stader, Saye Khoo, Marcel Stoeckle, David Back, Hans H. Hirsch, Manuel Battegay, Catia Marzolini

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Carta
    Salvar na lista
    Na minha lista:

Ferramentas de busca: